Altimmune Company Description

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis.

The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Altimmune, Inc.

Country	United States
Founded	1997
Industry	Biological Products, Except Diagnostic Substances
Employees	59
CEO	Jerome Durso

Contact Details

Address: 910 Clopper Road Gaithersburg, Maryland 20878 United States
Phone	240 654 1450
Website	altimmune.com

Stock Details

Ticker Symbol	0A4C
Exchange	London Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2836

Key Executives

Name	Position
Jerome Durso	Chief Executive Officer
Gregory Weaver	Chief Financial Officer